Chris Heberlig's Net Worth
$3.33 Million
Who is Chris Heberlig?
Chris Heberlig has an estimated net worth of $3.33 Million. This is based on reported shares across multiple companies, which include Kiniksa Pharmaceuticals, Ltd., ORGANOVO HOLDINGS, INC., and SYNAGEVA BIOPHARMA CORP.
SEC CIK
Chris Heberlig's CIK is 0001532217
Past Insider Trading and Trends
2012 was Chris Heberlig's most active year for acquiring shares with 7 total transactions. Chris Heberlig's most active month to acquire stocks was the month of May. 2012 was Chris Heberlig's most active year for disposing of shares, totalling 15 transactions. Chris Heberlig's most active month to dispose stocks was the month of February. 2015 saw Chris Heberlig paying a total of $316,578.40 for 31,642 shares, this is the most they've acquired in one year. In 2014 Chris Heberlig cashed out on 27,540 shares for a total of $1,311,962.69, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Kiniksa Pharmaceuticals, Ltd. (KNSA) Snapshot price: $24.93
EVP & CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 20
| |||
Form 4
| +17.46% | 6.39K |
—
|
—
| 42.99K |
Feb 9 - May 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ORGANOVO HOLDINGS, INC. (ONVO) Snapshot price: $0.55
President and CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SYNAGEVA BIOPHARMA CORP No price found
SVP, Finance & Business Ops.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -24.39K |
$78.87 | $4,416.72 |
0
|
Jun 22
| |||
Form 4
| +6,153.85% | 24K |
—
|
—
| 24.39K |
Jun 5
| |||
Form 4
| +28.29% | 86 |
$72.16 | -$461,578.52 | 390 |
Scheduled
|
Mar 11
| ||
Form 4
|
—
|
0
|
$55.15 | -$439,100.56 | 304 |
Scheduled
|
Dec 29
| ||
Form 4
| +58.33% | 112 |
$54.89 | $6,147.68 | 304 |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
$57.04 | -$637,068.13 | 192 |
Scheduled
|
Mar 12
| ||
Form 4
|
∞
| 192 |
$36.30 | $6,969.60 | 192 |
Dec 31
| |||
Form 4
|
—
|
0
|
$24.75 | -$119,550.99 |
0
|
Scheduled
|
Jul 15 - Jul 16
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
$23.44 | -$179,905.20 |
0
|
Scheduled
|
Dec 19
| ||
Form 4
|
—
|
0
|
$25.49 | -$193,320.00 |
0
|
Scheduled
|
Oct 17
| ||
Form 4
|
—
|
0
|
$25.03 | -$48,150.00 |
0
|
Scheduled
|
Sep 4
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 4
|
—
|
0
|
$18.34 | -$34,783.00 |
0
|
Scheduled
|
Jun 1
| ||
Form 4
|
—
|
0
|
$18.92 | -$161,685.00 |
0
|
Scheduled
|
Feb 27
| ||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||